T, I., Y, M., N, E., SM, P., BM, B., L, W., . . . A, E. (2022). Correction: Pharmacologic conversion of cancer-associated fibroblasts from a protumor phenotype to an antitumor phenotype improves the sensitivity of pancreatic cancer to chemotherapeutics. Oncogene, 41(23), 3302. https://doi.org/10.1038/s41388-022-02336-4
Chicago Style (17th ed.) CitationT, Iida, et al. "Correction: Pharmacologic Conversion of Cancer-associated Fibroblasts from a Protumor Phenotype to an Antitumor Phenotype Improves the Sensitivity of Pancreatic Cancer to Chemotherapeutics." Oncogene 41, no. 23 (2022): 3302. https://doi.org/10.1038/s41388-022-02336-4.
MLA (9th ed.) CitationT, Iida, et al. "Correction: Pharmacologic Conversion of Cancer-associated Fibroblasts from a Protumor Phenotype to an Antitumor Phenotype Improves the Sensitivity of Pancreatic Cancer to Chemotherapeutics." Oncogene, vol. 41, no. 23, 2022, p. 3302, https://doi.org/10.1038/s41388-022-02336-4.